|
1.
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Busson P, Keryer C, Ooka T and Corbex M:
EBV-associated nasopharyngeal carcinomas: from epidemiology to
virus-targeting strategies. Trends Microbiol. 12:356–360. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
No authors listed: Cancer incidence in
five continents Volume VIII. IARC Sci Publ. 2002:1–781. 2002.
|
|
4.
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Yi JL, Gao L, Huang XD, et al:
Nasopharyngeal carcinoma treated by radical radiotherapy alone:
Ten-year experience of a single institution. Int J Radiat Oncol
Biol Phys. 65:161–168. 2006.PubMed/NCBI
|
|
6.
|
Chen CY, Han F, Zhao C, et al: Treatment
results and late complications of 556 patients with locally
advanced nasopharyngeal carcinoma treated with radiotherapy alone.
Br J Radiol. 82:452–458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Lee AW, Sze WM, Au JS, et al: Treatment
results for nasopharyngeal carcinoma in the modern era: the Hong
Kong experience. Int J Radiat Oncol Biol Phys. 61:1107–1116. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Lee AW, Poon YF, Foo W, et al:
Retrospective analysis of 5037 patients with nasopharyngeal
carcinoma treated during 1976–1985 overall survival and patterns of
failure. Int J Radiat Oncol Biol Phys. 23:261–270. 1992.PubMed/NCBI
|
|
9.
|
Kwong DL, Pow EH, Sham JS, et al:
Intensity-modulated radiotherapy for early-stage nasopharyngeal
carcinoma: a prospective study on disease control and preservation
of salivary function. Cancer. 101:1584–1593. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kam MK, Leung SF, Zee B, et al:
Prospective randomized study of intensity-modulated radiotherapy on
salivary gland function in early-stage nasopharyngeal carcinoma
patients. J Clin Oncol. 25:4873–4879. 2007. View Article : Google Scholar
|
|
11.
|
Lee N, Harris J, Garden AS, et al:
Intensity-modulated radiation therapy with or without chemotherapy
for nasopharyngeal carcinoma: radiation therapy oncology group
phase II trial 0225. J Clin Oncol. 27:3684–3690. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
He X, Ou D, Ying H, Zhu G, Hu C and Liu T:
Experience with combination of cisplatin plus gemcitabine
chemotherapy and intensity-modulated radiotherapy for
locoregionally advanced nasopharyngeal carcinoma. Eur Arch
Otorhinolaryngol. 269:1027–1033. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Xiao WW, Huang SM, Han F, et al: Local
control, survival, and late toxicities of locally advanced
nasopharyngeal carcinoma treated by simultaneous modulated
accelerated radiotherapy combined with cisplatin concurrent
chemotherapy: long-term results of a phase 2 study. Cancer.
117:1874–1883. 2011. View Article : Google Scholar
|
|
14.
|
Langendijk JA, Leemans CR, Buter J,
Berkhof J and Slotman BJ: The additional value of chemotherapy to
radiotherapy in locally advanced nasopharyngeal carcinoma: a
meta-analysis of the published literature. J Clin Oncol.
22:4604–4612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Baujat B, Audry H, Bourhis J, et al:
Chemotherapy in locally advanced nasopharyngeal carcinoma: an
individual patient data meta-analysis of eight randomized trials
and 1753 patients. Int J Radiat Oncol Biol Phys. 64:47–56. 2006.
View Article : Google Scholar
|
|
16.
|
Chua DT, Sham JS, Kwong DL and Au GK:
Treatment outcome after radiotherapy alone for patients with stage
I–II nasopharyngeal carcinoma. Cancer. 98:74–80. 2003.PubMed/NCBI
|
|
17.
|
Yeh SA, Tang Y, Lui CC, Huang YJ and Huang
EY: Treatment outcomes and late complications of 849 patients with
nasopharyngeal carcinoma treated with radiotherapy alone. Int J
Radiat Oncol Biol Phys. 62:672–679. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Chow E, Payne D, O’Sullivan B, et al:
Radiotherapy alone in patients with advanced nasopharyngeal cancer:
comparison with an intergroup study. Is combined modality treatment
really necessary? Radiother Oncol. 63:269–274. 2002. View Article : Google Scholar
|
|
19.
|
Xiao WW, Han F, Lu TX, Chen CY, Huang Y
and Zhao C: Treatment outcomes after radiotherapy alone for
patients with early-stage nasopharyngeal carcinoma. Int J Radiat
Oncol Biol Phys. 74:1070–1076. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Xia P, Fu KK, Wong GW, Akazawa C and
Verhey LJ: Comparison of treatment plans involving
intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int
J Radiat Oncol Biol Phys. 48:329–337. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Cheng JC, Chao KS and Low D: Comparison of
intensity modulated radiation therapy (IMRT) treatment techniques
for nasopharyngeal carcinoma. Int J Cancer. 96:126–131. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kam MK, Chau RM, Suen J, Choi PH and Teo
PM: Intensity-modulated radiotherapy in nasopharyngeal carcinoma:
dosimetric advantage over conventional plans and feasibility of
dose escalation. Int J Radiat Oncol Biol Phys. 56:145–157. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Wu VW, Kwong DL and Sham JS: Target dose
conformity in 3-dimensional conformal radiotherapy and intensity
modulated radiotherapy. Radiother Oncol. 71:201–206. 2004.
View Article : Google Scholar
|
|
24.
|
Veldeman L, Madani I, Hulstaert F, De
Meerleer G, Mareel M and De Neve W: Evidence behind use of
intensity-modulated radiotherapy: a systematic review of
comparative clinical studies. Lancet Oncol. 9:367–375. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Lee N, Xia P, Quivey JM, et al:
Intensity-modulated radiotherapy in the treatment of nasopharyngeal
carcinoma: an update of the UCSF experience. Int J Radiat Oncol
Biol Phys. 53:12–22. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Kam MK, Teo PM, Chau RM, et al: Treatment
of nasopharyngeal carcinoma with intensity-modulated radiotherapy:
the Hong Kong experience. Int J Radiat Oncol Biol Phys.
60:1440–1450. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Wolden SL, Chen WC, Pfister DG, Kraus DH,
Berry SL and Zelefsky MJ: Intensity-modulated radiation therapy
(IMRT) for nasopharynx cancer: update of the Memorial
Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 64:57–62.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Ng WT, Lee MC, Hung WM, et al: Clinical
outcomes and patterns of failure after intensity-modulated
radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol
Phys. 79:420–428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Su SF, Han F, Zhao C, et al: Long-term
outcomes of early-stage nasopharyngeal carcinoma patients treated
with intensity-modulated radiotherapy alone. Int J Radiat Oncol
Biol Phys. 82:327–333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Lin S, Lu JJ, Han L, Chen Q and Pan J:
Sequential chemotherapy and intensity-modulated radiation therapy
in the management of locoregionally advanced nasopharyngeal
carcinoma: experience of 370 consecutive cases. BMC Cancer.
10:392010. View Article : Google Scholar
|
|
31.
|
Lin S, Pan J, Han L, Zhang X, Liao X and
Lu JJ: Nasopharyngeal carcinoma treated with reduced-volume
intensity-modulated radiation therapy: report on the 3-year outcome
of a prospective series. Int J Radiat Oncol Biol Phys.
75:1071–1078. 2009.PubMed/NCBI
|
|
32.
|
Tham IW, Hee SW, Yeo RM, et al: Treatment
of nasopharyngeal carcinoma using intensity-modulated radiotherapy
- the National Cancer Centre Singapore experience. Int J Radiat
Oncol Biol Phys. 75:1481–1486. 2009. View Article : Google Scholar : PubMed/NCBI
|
